世界のワクチン受託製造市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Vaccine Contract Manufacturing Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5010 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、ワクチン受託製造の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（充填仕上げ、バルク製品）、用途別市場規模（製薬企業、バイオ企業、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ワクチン受託製造の市場動向 ・企業の競争状況、市場シェア ・ワクチン受託製造の種類別市場規模と予測2016-2027（充填仕上げ、バルク製品） ・ワクチン受託製造の用途別市場規模と予測2016-2027（製薬企業、バイオ企業、その他） ・ワクチン受託製造の北米市場規模2016-2027（アメリカ、カナダ） ・ワクチン受託製造の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ワクチン受託製造のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ワクチン受託製造の中南米市場規模2016-2027（メキシコ、ブラジル） ・ワクチン受託製造の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Diosynth、Emergent BioSolutions、Goodwin Biotechnology、Bavarian Nordic、Soligenix Inc、Catalent Biologics） ・結論

Market Analysis and Insights: Global Vaccine Contract Manufacturing Market
The global Vaccine Contract Manufacturing market size is projected to reach US$ 2558.5 million by 2027, from US$ 1731.5 million in 2020, at a CAGR of 5.3% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Vaccine Contract Manufacturing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Vaccine Contract Manufacturing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Vaccine Contract Manufacturing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Vaccine Contract Manufacturing market.

Global Vaccine Contract Manufacturing Scope and Market Size
Vaccine Contract Manufacturing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vaccine Contract Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Fill-Finish
Bulk Product

Segment by Application
Pharmaceutical Companies
Biotech Companies
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Diosynth
Emergent BioSolutions
Goodwin Biotechnology
Bavarian Nordic
Soligenix Inc
Catalent Biologics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccine Contract Manufacturing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Fill-Finish
1.2.3 Bulk Product
1.3 Market by Application
1.3.1 Global Vaccine Contract Manufacturing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical Companies
1.3.3 Biotech Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Vaccine Contract Manufacturing Market Perspective (2016-2027)
2.2 Vaccine Contract Manufacturing Growth Trends by Regions
2.2.1 Vaccine Contract Manufacturing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Vaccine Contract Manufacturing Historic Market Share by Regions (2016-2021)
2.2.3 Vaccine Contract Manufacturing Forecasted Market Size by Regions (2022-2027)
2.3 Vaccine Contract Manufacturing Industry Dynamic
2.3.1 Vaccine Contract Manufacturing Market Trends
2.3.2 Vaccine Contract Manufacturing Market Drivers
2.3.3 Vaccine Contract Manufacturing Market Challenges
2.3.4 Vaccine Contract Manufacturing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Vaccine Contract Manufacturing Players by Revenue
3.1.1 Global Top Vaccine Contract Manufacturing Players by Revenue (2016-2021)
3.1.2 Global Vaccine Contract Manufacturing Revenue Market Share by Players (2016-2021)
3.2 Global Vaccine Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Vaccine Contract Manufacturing Revenue
3.4 Global Vaccine Contract Manufacturing Market Concentration Ratio
3.4.1 Global Vaccine Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccine Contract Manufacturing Revenue in 2020
3.5 Vaccine Contract Manufacturing Key Players Head office and Area Served
3.6 Key Players Vaccine Contract Manufacturing Product Solution and Service
3.7 Date of Enter into Vaccine Contract Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Vaccine Contract Manufacturing Breakdown Data by Type
4.1 Global Vaccine Contract Manufacturing Historic Market Size by Type (2016-2021)
4.2 Global Vaccine Contract Manufacturing Forecasted Market Size by Type (2022-2027)

5 Vaccine Contract Manufacturing Breakdown Data by Application
5.1 Global Vaccine Contract Manufacturing Historic Market Size by Application (2016-2021)
5.2 Global Vaccine Contract Manufacturing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Vaccine Contract Manufacturing Market Size (2016-2027)
6.2 North America Vaccine Contract Manufacturing Market Size by Type
6.2.1 North America Vaccine Contract Manufacturing Market Size by Type (2016-2021)
6.2.2 North America Vaccine Contract Manufacturing Market Size by Type (2022-2027)
6.2.3 North America Vaccine Contract Manufacturing Market Size by Type (2016-2027)
6.3 North America Vaccine Contract Manufacturing Market Size by Application
6.3.1 North America Vaccine Contract Manufacturing Market Size by Application (2016-2021)
6.3.2 North America Vaccine Contract Manufacturing Market Size by Application (2022-2027)
6.3.3 North America Vaccine Contract Manufacturing Market Size by Application (2016-2027)
6.4 North America Vaccine Contract Manufacturing Market Size by Country
6.4.1 North America Vaccine Contract Manufacturing Market Size by Country (2016-2021)
6.4.2 North America Vaccine Contract Manufacturing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Vaccine Contract Manufacturing Market Size (2016-2027)
7.2 Europe Vaccine Contract Manufacturing Market Size by Type
7.2.1 Europe Vaccine Contract Manufacturing Market Size by Type (2016-2021)
7.2.2 Europe Vaccine Contract Manufacturing Market Size by Type (2022-2027)
7.2.3 Europe Vaccine Contract Manufacturing Market Size by Type (2016-2027)
7.3 Europe Vaccine Contract Manufacturing Market Size by Application
7.3.1 Europe Vaccine Contract Manufacturing Market Size by Application (2016-2021)
7.3.2 Europe Vaccine Contract Manufacturing Market Size by Application (2022-2027)
7.3.3 Europe Vaccine Contract Manufacturing Market Size by Application (2016-2027)
7.4 Europe Vaccine Contract Manufacturing Market Size by Country
7.4.1 Europe Vaccine Contract Manufacturing Market Size by Country (2016-2021)
7.4.2 Europe Vaccine Contract Manufacturing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Vaccine Contract Manufacturing Market Size (2016-2027)
8.2 Asia-Pacific Vaccine Contract Manufacturing Market Size by Type
8.2.1 Asia-Pacific Vaccine Contract Manufacturing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Vaccine Contract Manufacturing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Vaccine Contract Manufacturing Market Size by Type (2016-2027)
8.3 Asia-Pacific Vaccine Contract Manufacturing Market Size by Application
8.3.1 Asia-Pacific Vaccine Contract Manufacturing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Vaccine Contract Manufacturing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Vaccine Contract Manufacturing Market Size by Application (2016-2027)
8.4 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region
8.4.1 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Vaccine Contract Manufacturing Market Size (2016-2027)
9.2 Latin America Vaccine Contract Manufacturing Market Size by Type
9.2.1 Latin America Vaccine Contract Manufacturing Market Size by Type (2016-2021)
9.2.2 Latin America Vaccine Contract Manufacturing Market Size by Type (2022-2027)
9.2.3 Latin America Vaccine Contract Manufacturing Market Size by Type (2016-2027)
9.3 Latin America Vaccine Contract Manufacturing Market Size by Application
9.3.1 Latin America Vaccine Contract Manufacturing Market Size by Application (2016-2021)
9.3.2 Latin America Vaccine Contract Manufacturing Market Size by Application (2022-2027)
9.3.3 Latin America Vaccine Contract Manufacturing Market Size by Application (2016-2027)
9.4 Latin America Vaccine Contract Manufacturing Market Size by Country
9.4.1 Latin America Vaccine Contract Manufacturing Market Size by Country (2016-2021)
9.4.2 Latin America Vaccine Contract Manufacturing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Vaccine Contract Manufacturing Market Size (2016-2027)
10.2 Middle East & Africa Vaccine Contract Manufacturing Market Size by Type
10.2.1 Middle East & Africa Vaccine Contract Manufacturing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Vaccine Contract Manufacturing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Vaccine Contract Manufacturing Market Size by Type (2016-2027)
10.3 Middle East & Africa Vaccine Contract Manufacturing Market Size by Application
10.3.1 Middle East & Africa Vaccine Contract Manufacturing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Vaccine Contract Manufacturing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Vaccine Contract Manufacturing Market Size by Application (2016-2027)
10.4 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country
10.4.1 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Diosynth
11.1.1 Diosynth Company Details
11.1.2 Diosynth Business Overview
11.1.3 Diosynth Vaccine Contract Manufacturing Introduction
11.1.4 Diosynth Revenue in Vaccine Contract Manufacturing Business (2016-2021)
11.1.5 Diosynth Recent Development
11.2 Emergent BioSolutions
11.2.1 Emergent BioSolutions Company Details
11.2.2 Emergent BioSolutions Business Overview
11.2.3 Emergent BioSolutions Vaccine Contract Manufacturing Introduction
11.2.4 Emergent BioSolutions Revenue in Vaccine Contract Manufacturing Business (2016-2021)
11.2.5 Emergent BioSolutions Recent Development
11.3 Goodwin Biotechnology
11.3.1 Goodwin Biotechnology Company Details
11.3.2 Goodwin Biotechnology Business Overview
11.3.3 Goodwin Biotechnology Vaccine Contract Manufacturing Introduction
11.3.4 Goodwin Biotechnology Revenue in Vaccine Contract Manufacturing Business (2016-2021)
11.3.5 Goodwin Biotechnology Recent Development
11.4 Bavarian Nordic
11.4.1 Bavarian Nordic Company Details
11.4.2 Bavarian Nordic Business Overview
11.4.3 Bavarian Nordic Vaccine Contract Manufacturing Introduction
11.4.4 Bavarian Nordic Revenue in Vaccine Contract Manufacturing Business (2016-2021)
11.4.5 Bavarian Nordic Recent Development
11.5 Soligenix Inc
11.5.1 Soligenix Inc Company Details
11.5.2 Soligenix Inc Business Overview
11.5.3 Soligenix Inc Vaccine Contract Manufacturing Introduction
11.5.4 Soligenix Inc Revenue in Vaccine Contract Manufacturing Business (2016-2021)
11.5.5 Soligenix Inc Recent Development
11.6 Catalent Biologics
11.6.1 Catalent Biologics Company Details
11.6.2 Catalent Biologics Business Overview
11.6.3 Catalent Biologics Vaccine Contract Manufacturing Introduction
11.6.4 Catalent Biologics Revenue in Vaccine Contract Manufacturing Business (2016-2021)
11.6.5 Catalent Biologics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Vaccine Contract Manufacturing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Fill-Finish
Table 3. Key Players of Bulk Product
Table 4. Global Vaccine Contract Manufacturing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Vaccine Contract Manufacturing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Vaccine Contract Manufacturing Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Vaccine Contract Manufacturing Market Share by Regions (2016-2021)
Table 8. Global Vaccine Contract Manufacturing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Vaccine Contract Manufacturing Market Share by Regions (2022-2027)
Table 10. Vaccine Contract Manufacturing Market Trends
Table 11. Vaccine Contract Manufacturing Market Drivers
Table 12. Vaccine Contract Manufacturing Market Challenges
Table 13. Vaccine Contract Manufacturing Market Restraints
Table 14. Global Vaccine Contract Manufacturing Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Vaccine Contract Manufacturing Market Share by Players (2016-2021)
Table 16. Global Top Vaccine Contract Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine Contract Manufacturing as of 2020)
Table 17. Ranking of Global Top Vaccine Contract Manufacturing Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Vaccine Contract Manufacturing Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Vaccine Contract Manufacturing Product Solution and Service
Table 21. Date of Enter into Vaccine Contract Manufacturing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Vaccine Contract Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Vaccine Contract Manufacturing Revenue Market Share by Type (2016-2021)
Table 25. Global Vaccine Contract Manufacturing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Vaccine Contract Manufacturing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Vaccine Contract Manufacturing Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Vaccine Contract Manufacturing Revenue Market Share by Application (2016-2021)
Table 29. Global Vaccine Contract Manufacturing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Vaccine Contract Manufacturing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Vaccine Contract Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Vaccine Contract Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Vaccine Contract Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Vaccine Contract Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Vaccine Contract Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Vaccine Contract Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Vaccine Contract Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Vaccine Contract Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Vaccine Contract Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Vaccine Contract Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Vaccine Contract Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Vaccine Contract Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Vaccine Contract Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Vaccine Contract Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Vaccine Contract Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Vaccine Contract Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Vaccine Contract Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Vaccine Contract Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Vaccine Contract Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Vaccine Contract Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Vaccine Contract Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Vaccine Contract Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Vaccine Contract Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Vaccine Contract Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Vaccine Contract Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Vaccine Contract Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 61. Diosynth Company Details
Table 62. Diosynth Business Overview
Table 63. Diosynth Vaccine Contract Manufacturing Product
Table 64. Diosynth Revenue in Vaccine Contract Manufacturing Business (2016-2021) & (US$ Million)
Table 65. Diosynth Recent Development
Table 66. Emergent BioSolutions Company Details
Table 67. Emergent BioSolutions Business Overview
Table 68. Emergent BioSolutions Vaccine Contract Manufacturing Product
Table 69. Emergent BioSolutions Revenue in Vaccine Contract Manufacturing Business (2016-2021) & (US$ Million)
Table 70. Emergent BioSolutions Recent Development
Table 71. Goodwin Biotechnology Company Details
Table 72. Goodwin Biotechnology Business Overview
Table 73. Goodwin Biotechnology Vaccine Contract Manufacturing Product
Table 74. Goodwin Biotechnology Revenue in Vaccine Contract Manufacturing Business (2016-2021) & (US$ Million)
Table 75. Goodwin Biotechnology Recent Development
Table 76. Bavarian Nordic Company Details
Table 77. Bavarian Nordic Business Overview
Table 78. Bavarian Nordic Vaccine Contract Manufacturing Product
Table 79. Bavarian Nordic Revenue in Vaccine Contract Manufacturing Business (2016-2021) & (US$ Million)
Table 80. Bavarian Nordic Recent Development
Table 81. Soligenix Inc Company Details
Table 82. Soligenix Inc Business Overview
Table 83. Soligenix Inc Vaccine Contract Manufacturing Product
Table 84. Soligenix Inc Revenue in Vaccine Contract Manufacturing Business (2016-2021) & (US$ Million)
Table 85. Soligenix Inc Recent Development
Table 86. Catalent Biologics Company Details
Table 87. Catalent Biologics Business Overview
Table 88. Catalent Biologics Vaccine Contract Manufacturing Product
Table 89. Catalent Biologics Revenue in Vaccine Contract Manufacturing Business (2016-2021) & (US$ Million)
Table 90. Catalent Biologics Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vaccine Contract Manufacturing Market Share by Type: 2020 VS 2027
Figure 2. Fill-Finish Features
Figure 3. Bulk Product Features
Figure 4. Global Vaccine Contract Manufacturing Market Share by Application: 2020 VS 2027
Figure 5. Pharmaceutical Companies Case Studies
Figure 6. Biotech Companies Case Studies
Figure 7. Others Case Studies
Figure 8. Vaccine Contract Manufacturing Report Years Considered
Figure 9. Global Vaccine Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Vaccine Contract Manufacturing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Vaccine Contract Manufacturing Market Share by Regions: 2020 VS 2027
Figure 12. Global Vaccine Contract Manufacturing Market Share by Regions (2022-2027)
Figure 13. Global Vaccine Contract Manufacturing Market Share by Players in 2020
Figure 14. Global Top Vaccine Contract Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine Contract Manufacturing as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Vaccine Contract Manufacturing Revenue in 2020
Figure 16. Global Vaccine Contract Manufacturing Revenue Market Share by Type (2016-2021)
Figure 17. Global Vaccine Contract Manufacturing Revenue Market Share by Type (2022-2027)
Figure 18. North America Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Vaccine Contract Manufacturing Market Share by Type (2016-2027)
Figure 20. North America Vaccine Contract Manufacturing Market Share by Application (2016-2027)
Figure 21. North America Vaccine Contract Manufacturing Market Share by Country (2016-2027)
Figure 22. United States Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Vaccine Contract Manufacturing Market Share by Type (2016-2027)
Figure 26. Europe Vaccine Contract Manufacturing Market Share by Application (2016-2027)
Figure 27. Europe Vaccine Contract Manufacturing Market Share by Country (2016-2027)
Figure 28. Germany Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Vaccine Contract Manufacturing Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Vaccine Contract Manufacturing Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Vaccine Contract Manufacturing Market Share by Region (2016-2027)
Figure 38. China Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Vaccine Contract Manufacturing Market Share by Type (2016-2027)
Figure 46. Latin America Vaccine Contract Manufacturing Market Share by Application (2016-2027)
Figure 47. Latin America Vaccine Contract Manufacturing Market Share by Country (2016-2027)
Figure 48. Mexico Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Vaccine Contract Manufacturing Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Vaccine Contract Manufacturing Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Vaccine Contract Manufacturing Market Share by Country (2016-2027)
Figure 54. Turkey Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Vaccine Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Diosynth Revenue Growth Rate in Vaccine Contract Manufacturing Business (2016-2021)
Figure 58. Emergent BioSolutions Revenue Growth Rate in Vaccine Contract Manufacturing Business (2016-2021)
Figure 59. Goodwin Biotechnology Revenue Growth Rate in Vaccine Contract Manufacturing Business (2016-2021)
Figure 60. Bavarian Nordic Revenue Growth Rate in Vaccine Contract Manufacturing Business (2016-2021)
Figure 61. Soligenix Inc Revenue Growth Rate in Vaccine Contract Manufacturing Business (2016-2021)
Figure 62. Catalent Biologics Revenue Growth Rate in Vaccine Contract Manufacturing Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

---